BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21505656)

  • 1. Secretome profiling with antibody microarrays.
    Mustafa SA; Hoheisel JD; Alhamdani MS
    Mol Biosyst; 2011 Jun; 7(6):1795-801. PubMed ID: 21505656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches for systematic proteome exploration.
    Falk R; Ramström M; Ståhl S; Hober S
    Biomol Eng; 2007 Jun; 24(2):155-68. PubMed ID: 17376740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells.
    Paulitschke V; Kunstfeld R; Mohr T; Slany A; Micksche M; Drach J; Zielinski C; Pehamberger H; Gerner C
    J Proteome Res; 2009 May; 8(5):2501-10. PubMed ID: 19222175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein and small molecule microarrays: powerful tools for high-throughput proteomics.
    Uttamchandani M; Wang J; Yao SQ
    Mol Biosyst; 2006 Jan; 2(1):58-68. PubMed ID: 16880923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput proteomics using antibody microarrays.
    Wingren C; Borrebaeck CA
    Expert Rev Proteomics; 2004 Oct; 1(3):355-64. PubMed ID: 15966831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An introduction into proteomics and its clinical applications.
    Ahram M
    Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF; Haab BB; Hanash SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody microarrays as tools for biomarker discovery.
    Sanchez-Carbayo M
    Methods Mol Biol; 2011; 785():159-82. PubMed ID: 21901599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
    Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
    Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics analysis of nasopharyngeal carcinoma cell secretome using a hollow fiber culture system and mass spectrometry.
    Wu HY; Chang YH; Chang YC; Liao PC
    J Proteome Res; 2009 Jan; 8(1):380-9. PubMed ID: 19012429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic technology and its biomedical applications.
    Lau AT; He QY; Chiu JF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput proteomics using antibody microarrays: an update.
    Borrebaeck CA; Wingren C
    Expert Rev Mol Diagn; 2007 Sep; 7(5):673-86. PubMed ID: 17892372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic antibody and antigen-based proteomic profiling with microarrays.
    Ayoglu B; Häggmark A; Neiman M; Igel U; Uhlén M; Schwenk JM; Nilsson P
    Expert Rev Mol Diagn; 2011 Mar; 11(2):219-34. PubMed ID: 21405972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lucid Proteomics System for top-down biomarker research.
    Jourdain S; Bulman A; Dalmasso E
    Arch Physiol Biochem; 2010; 116(4-5):158-62. PubMed ID: 20507259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein biochips: A new and versatile platform technology for molecular medicine.
    Lueking A; Cahill DJ; Müllner S
    Drug Discov Today; 2005 Jun; 10(11):789-94. PubMed ID: 15922937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.
    Schwamborn K; Gaisa NT; Henkel C
    Expert Rev Proteomics; 2010 Dec; 7(6):897-906. PubMed ID: 21142890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of high-density antibody microarrays for disease proteomics: key technological issues.
    Borrebaeck CA; Wingren C
    J Proteomics; 2009 Aug; 72(6):928-35. PubMed ID: 19457338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.
    Carlsson A; Wingren C; Ingvarsson J; Ellmark P; Baldertorp B; Fernö M; Olsson H; Borrebaeck CA
    Eur J Cancer; 2008 Feb; 44(3):472-80. PubMed ID: 18171612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.